Transplantation of human umbilical cord blood-derived mesenchymal stem cells for treatment of acute myocardial infarction in rats
10.3969/j.issn.2095-4344.2015.41.011
- VernacularTitle:胎儿脐血间充质干细胞治疗大鼠急性心肌梗死
- Author:
Wei WANG
;
Xiaofu LI
;
Zhongjian LI
- Publication Type:Journal Article
- Keywords:
Myocardium;
Blood Vessels;
Cord Blood Stem Cel Transplantation;
Coronary Occlusion;
Tissue Engineering
- From:
Chinese Journal of Tissue Engineering Research
2015;(41):6616-6622
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Human umbilical cord blood-derived mesenchymal stem cels are able to repair and regenerate the injured myocardium, which is a new therapy for myocardial infarctionvia transplantation. OBJECTIVE:To explore the therapeutic efficacy of intracoronary injection of human umbilical cord blood-derived mesenchymal stem cels on acute myocardial infarction in rats. METHODS:Thirty-two rats were selected to make animal models of ligation of the left anterior descending coronary, and then model rats were randomized equaly to transplantation group and model group. Human umbilical cord blood-derived mesenchymal stem cels were isolated and prepared into cel suspension. Rats in the transplantation group were subjected to transplantation of human umbilical cord blood-derived mesenchymal stem cels. RESULTS AND CONCLUSION: Human umbilical cord blood-derived mesenchymal stem cels were successfuly isolated and cultured in vitro. Compared with the model group, the microvessel density, left ventricular end-systolic pressure and ±dp/dtmax were significantly increased in the transplantation group (P < 0.05), while the left ventricular end-diastolic pressure was decreased dramaticaly (P < 0.05). Electrocardiography findings showed that the heart function of rats in the transplantation group was improved slightly. These findings indicate that human umbilical cord blood-derived mesenchymal stem cels can promote myocardial angiogenesis and improve heart function of rats with myocardial infarction.
